Bohen Sean - Insider Non-Derivative Transactions at Olema Pharmaceuticals, Inc. (OLMA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 26, 2025, Bohen Sean's relationship to Olema Pharmaceuticals, Inc. (OLMA) is Director,Officer (President and CEO), and currently has 237,650 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other OLMA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Bohen Sean - Insider Non-Derivative Transactions of OLMA Common Stock

Bohen Sean - Insider Non-Derivative Transactions at OLMA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 27, 2025	G -- (Common Stock)	8500	0	237650
Dec 12, 2024	Sell -- (Common Stock)	1267	9.39	241662
Dec 12, 2024	Sell -- (Common Stock)	55907	8.66	242929
Dec 11, 2024	Sell -- (Common Stock)	52328	9.37	298836
Dec 10, 2024	Acquisition -- (Common Stock)	204750	0	351164
Nov 23, 2023	Sell -- (Common Stock)	27932	13.9	144925
Nov 22, 2023	Sell -- (Common Stock)	2602	15.29	172857
Nov 22, 2023	Sell -- (Common Stock)	26691	14.84	175459
Nov 21, 2023	Acquisition -- (Common Stock)	110250	0	202150